New UNC laboratory to help track and control tropical diseasesSeptember 26, 2008CHAPEL HILL - The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods. Better information about the prevalence and location of diseases will help national and international health organizations around the world treat and control these diseases. Steven R. Meshnick, M.D., Ph.D., UNC an epidemiology professor in the School of Public Health and an expert on molecular epidemiology and infectious diseases, will lead the new project, known as the laboratory for molecular surveillance of tropical diseases. The lab will work with the research and evaluation company ORC-Macro, the Institute of Tropical Medicine in Antwerp, Belgium, and the Kinshasa School of Public Health in the Democratic Republic of Congo. Together, the group will measure the distribution of malaria, drug-resistant malaria, African sleeping sickness and other infectious diseases in the Democratic Republic of Congo. "Infectious diseases remain the leading cause of death and disability in developing countries," Meshnick said. "Current maps and prevalence data on tropical diseases are usually estimates based on samples that paint a potentially inaccurate picture. We want to help international and national health organizations get better data and maps for tropical diseases from representative population-based surveys. Better information will help guide efforts to control tropical diseases, and also will help in evaluating the effectiveness of efforts to control their spread." The team includes geographer Mike Emch, Ph.D., associate professor in the College of Arts and Sciences, and molecular microbiologist, Melissa Miller, Ph.D., assistant professor in the pathology and laboratory medicine department in the School of Medicine. It also includes Democratic Republic of Congo scientists, which should help build expertise within the country. Meshnick said he hoped the new lab's disease surveillance approach will become a model for similar surveillance programs in other developing countries. "This work will help the 'poorest of the poor,' who bear the brunt of the burden of tropical diseases," Meshnick said. The team's initial work will involve analyzing 9,000 dried blood spots collected in 2007 for tracking HIV infection. The Gillings Innovation Labs, part of Carolina Public Health Solutions, were established in the school in 2007 and are funded through a $50 million gift pledged by Dennis and Joan Gillings. In honor of the gift, the school will be renamed the UNC Gillings School of Global Public Health on Friday (Sept. 26). The labs' purpose is to anticipate future public health challenges and accelerate solutions through groundbreaking science, research, teaching and practice, and through interdisciplinary teams and effective translation of interventions to high-impact settings. Meshnick's is the 10th such lab announced by the school. It will begin in January 2009 and continue for two years. Other Gillings Innovation Labs have been established to develop vaccines for respiratory diseases that are simpler to store and administer than current vaccines; provide greater access to safe and clean water; improve care for the mentally ill; monitor air quality; and weigh benefits of locally grown foods. University of North Carolina at Chapel Hill |
|||||||||||||||||||||
| Related Tropical Diseases Current Events and Tropical Diseases News Articles Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Population movement can be critical factor in dengue's spread Human movement is a key factor of dengue virus inflow in Rio de Janeiro, according to results from researchers based at the Oswaldo Cruz Foundation (Fiocruz) in Brazil. Pitt, US Army team designs new strategy to find drugs to treat neglected infection Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases. Global challenges and opportunities in fighting HIV/AIDS and neglected diseases Responding to the HIV/AIDS pandemic and tackling so-called neglected tropical diseases are the focus of the November/December 2009 edition of Health Affairs. Will genomics help prevent the next pandemic? This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease. Gut worms may protect against house-dust mite allergy A study conducted in Vietnam has added further weight to the view that parasitic gut worms, such as hookworm, could help in the prevention and treatment of asthma and other allergies. Discovery to aid in future treatments of third-world parasites Schistosomiasis, one of the most important of the neglected tropical diseases, is caused by infection with parasitic helminths of the genus Schistosoma. C. difficile spores spread superbug New research suggests that antibiotic treatment could be asymptomatically inducing the transmission of the healthcare-acquired infection, C. difficile, contributing to the outbreaks that have recently been widely reported in hospitals and other settings. Scientists decode genome of deadly parasitic worm Scientists have sequenced the genome of the parasite that causes intestinal schistosomiasis (also known as bilharzia or snail fever), a devastating tropical disease that afflicts more than 200 million people in the developing world. More Tropical Diseases Current Events and Tropical Diseases News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||